Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study

被引：0
|
作者：
Tang, Y. [1 ]
Wang, M. [1 ]
Liang, J. [1 ]
Zeng, H. [1 ]
机构：
[1] West China Hosp, Dept Urol, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306P
引用
收藏
页码：S1522 / S1522
页数：1
相关论文
共 50 条
  • [31] Clinical outcomes of patients with metastatic fumarate hydratase-deficient renal cell carcinoma: A single-center case series
    Yonese, Ichiro
    Takemura, Kosuke
    Yuasa, Takeshi
    Amori, Gulanbar
    Inamura, Kentaro
    Yonese, Junji
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
  • [32] Multi-Omics analysis of metastatic fumarate hydratase-deficient renal cell carcinoma in paired primary tumors and metastases
    Zhu, S.
    Liang, J.
    Zhang, X.
    Sun, G.
    Liu, Z.
    Zeng, H.
    EUROPEAN UROLOGY, 2022, 81 : S1637 - S1637
  • [33] Case report: A rare low-grade fumarate hydratase-deficient renal cell carcinoma
    Sun, Di
    Hu, Baohong
    Li, Xinna
    Yang, Ping
    Yu, Guohua
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience
    Mullane, Patrick C.
    Qian, Xiaohua
    Lau, Hubert D.
    Lowe, Alarice Cheng-Yi
    CANCER CYTOPATHOLOGY, 2025, 133 (02)
  • [35] EFFICACY AND SAFETY OF IMMUNE CHECKPOINT INHIBITOR RECHALLENGE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Scheiner, Bernhard
    Pomej, Katharina
    Pressiani, Tiziana
    Cammarota, Antonella
    Fruendt, Thorben W.
    Von Felden, Johann
    Schulze, Kornelius
    Roessler, Daniel
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Deibel, Ansgar
    Siebenhuner, Alexander
    Shmanko, Kateryna
    Radu, Pompilia
    Schwacha, Birgit
    Ebert, Matthias P.
    Teufel, Andreas
    Djanani, Angela
    Hucke, Florian
    Balcar, Lorenz
    Venerito, Marino
    Sinner, Friedrich
    Trauner, Michael H.
    D'Alessio, Antonio
    Pinato, David James
    Peck-Radosavljevic, Markus
    Dufour, Jean-Francois
    Weinmann, Arndt
    Kremer, Andreas E.
    De Toni, Enrico
    Rimassa, Lorenza
    Pinter, Matthias
    HEPATOLOGY, 2022, 76 : S1367 - S1369
  • [36] Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
    Scheiner, Bernhard
    Roessler, Daniel
    Phen, Samuel
    Lim, Mir
    Pomej, Katharina
    Pressiani, Tiziana
    Cammarota, Antonella
    Fruendt, Thorben W.
    von Felden, Johann
    Schulze, Kornelius
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Deibel, Ansgar
    Siebenhuener, Alexander R.
    Shmanko, Kateryna
    Radu, Pompilia
    Schwacha-Eipper, Birgit
    Ebert, Matthias P.
    Teufel, Andreas
    Djanani, Angela
    Hucke, Florian
    Balcar, Lorenz
    Philipp, Alexander B.
    Fulgenzi, Claudia A. M.
    Pinato, David J.
    Hsiehchen, David
    Venerito, Marino
    Sinner, Friedrich
    Trauner, Michael
    D'Alessio, Antonio
    Fulgenzi, Claudia A. M.
    Pinato, David J.
    Peck-Radosavljevic, Markus
    Dufour, Jean-Francois
    Weinmann, Arndt
    Kremer, Andreas E.
    Singal, Amit G.
    De Toni, Enrico N.
    Rimassa, Lorenza
    Pinter, Matthias
    JHEP REPORTS, 2023, 5 (01)
  • [37] The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma
    Bai, Junjie
    Li, Xiaoyan
    Wen, Yahui
    Lu, Qing
    Chen, Ru
    Liu, Rong
    Tong, Shangguan
    Ye, Yushi
    Lin, Jun
    Cai, Weizhong
    Kang, Deyong
    Chen, Jianhui
    AGING-US, 2024, 16 (04): : 3631 - 3646
  • [38] GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma
    Liu, Yang
    Dong, Yihan
    Gu, Yijin
    Xu, Haimin
    Fan, Yue
    Li, Xiangyun
    Dong, Lei
    Zhou, Luting
    Yang, Xiaoqun
    Wang, Chaofu
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 60
  • [39] A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study
    Wen, Hui
    Zheng, Linmao
    Zhang, Mengxin
    Pan, Xiuyi
    Wang, Duohao
    Qian, Jinyu
    Zhang, Xingming
    Zhou, Qiao
    Chen, Ni
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (04) : 810 - 816
  • [40] Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms
    Kuroda, Naoto
    Tsutsui, Miho
    Iguchi, Mitsuko
    Nobuoka, Emi
    Uehara, Takeshi
    Sonobe, Yuta
    Morinaga, Yukiko
    Shibuya, Shinsuke
    Oda, Wakako
    Yanai, Hiroyuki
    Kawada, Chiaki
    Karashima, Takashi
    Yamasaki, Ichiro
    Inoue, Keiji
    Nagashima, Yoji
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
12345